Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Compass Therapeutics (CMPX) Share-based Compensation (2023 - 2026)

Compass Therapeutics' Share-based Compensation history spans 4 years, with the latest figure at $5.1 million for Q1 2026.

  • On a quarterly basis, Share-based Compensation rose 101.79% to $5.1 million in Q1 2026 year-over-year; TTM through Mar 2026 was $10.9 million, a 20.46% increase, with the full-year FY2025 number at $8.4 million, down 2.24% from a year prior.
  • Share-based Compensation hit $5.1 million in Q1 2026 for Compass Therapeutics, up from $1.8 million in the prior quarter.
  • Over the last five years, Share-based Compensation for CMPX hit a ceiling of $5.1 million in Q1 2026 and a floor of $1.2 million in Q3 2025.
  • Historically, Share-based Compensation has averaged $2.2 million across 4 years, with a median of $2.0 million in 2024.
  • Biggest five-year swings in Share-based Compensation: tumbled 43.68% in 2025 and later skyrocketed 101.79% in 2026.
  • Tracing CMPX's Share-based Compensation over 4 years: stood at $1.6 million in 2023, then skyrocketed by 39.88% to $2.2 million in 2024, then fell by 18.45% to $1.8 million in 2025, then skyrocketed by 177.97% to $5.1 million in 2026.
  • Business Quant data shows Share-based Compensation for CMPX at $5.1 million in Q1 2026, $1.8 million in Q4 2025, and $1.2 million in Q3 2025.